Alternatives to Johnson & Johnson
Johnson & Johnson is a Pharmaceuticals tool: A global leader in healthcare, developing innovative solutions for consumer health, pharmaceuticals, and medical devices. Here are the 52 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Pharmaceuticals companies to Johnson & Johnson
Bausch HealthNot ratedGlobal pharmaceutical company focused on eye health, gastroenterology, and dermatology.
Procter & GambleNot ratedA multinational consumer goods corporation.
Advanced Accelerator ApplicationsNot ratedDevelops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.
Moderna2.0 out of 5 (1)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
BeiGeneNot ratedA global oncology company developing and commercializing innovative cancer treatments.
NucleaiNot ratedAI-powered spatial biology platform for precision medicine and drug development.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
4D PathNot ratedPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Rocket PharmaceuticalsNot ratedA biotechnology company developing genetic therapies for rare disorders.
Showing the next 20 closest matches. See the rest on the Johnson & Johnson profile.
Sponsored rows are paid and labelled. Advertise on this page
